Tadalafil

Details

Files

Generic Name:

Tadalafil

Project Status:

Complete

Therapeutic Area:

Pulmonary arterial hypertension

Manufacturer:

Eli Lilly Canada Inc.

Brand Name:

Adcirca

Project Line:

Reimbursement Review

Project Number:

SR0197-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Pulmonary arterial hypertension

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 15, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : February 5, 2010